Company
StemoniX
28bio Neurotechnology | Human Brain Organoids for Neurotoxicity Testing
- Business model
- B2B
- Legal name
- StemoniX, Inc.
Claim, correct or request removal
Record updated 28 September 2026
About
StemoniX is 28bio Neurotechnology. It is focused on human brain organoids for neurotoxicity testing.
Funding snapshot
- Total raised
- $14.6MSEC form D sum, as of 2026-09-28Source (opens in a new tab)
- Latest round
- Round, $100K2020-05-04
Funding rounds
- Round, 2020
- $100K2020-05-04, SEC form D sold, 3 investors
- Round, 2019
- $2.1M2019-09-27, SEC form D sold, 31 investors
- Round, 2018
- $1.4M2018-08-08, SEC form D sold, 7 investors
- Round, 2017
- $4.9M2017-10-24, SEC form D sold, 64 investors
- Round, 2017
- $2.4M2017-02-24, SEC form D sold, 16 investors
- Round, 2016
- $2.5M2016-07-22, SEC form D sold, 36 investors
- Round, 2015
- $1.1M2015-12-29, SEC form D sold, 9 investors
Loading relationship preview